Recent advances in CT imaging of liver metastases

Cancer Journal

Volumn 10, Issue 2, 2004, Pages 104-120

  Kamel, Ihab R ^a,b   Fishman, Elliot K ^a,b  

^a Johns Hopkins Hospital ^*

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

CT; Image processing; Liver metastases; Response criteria

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; HUMAN; IMAGE PROCESSING; LIVER METASTASIS; LIVER PARENCHYMA; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; CATHETER ABLATION; CHEMOEMBOLIZATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; LIVER TUMOR; METASTASIS; METHODOLOGY; PATHOLOGY; VASCULARIZATION;

CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; HUMANS; LIVER NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 4544296457     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200403000-00006     Document Type: Review

References (61)

1. Ackerman NB, Lien WM, Kondi ES et al. The blood supply of experimental liver metastases. I: The distribution of hepatic artery and portal vein blood to "small" and "large" tumors. Surgery 1969; 66:1067-1072.
2. Baker ME, Pelley R. Hepatic metastases: basic principles and implications for radiologists. Radiology 1995;197:329-337.
3. Weiss L, Grundmann E, Torhorst J et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986;150:195-203.
4. Scheele J, Stang R, Altendorf-Hofmann A et al. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
5. Sugarbaker PH. Surgical decision making for large bowel cancer metastatic to the liver. Radiology 1990;174:621-626.
6. Fong Y, Cohen AM, Fortner JG et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-946.
7. Foley WD, Mallisee TA, Hohenwalter MD et al. Multiphase hepatic CT with a multirow detector CT scanner. AJR Am J Roentgenol 2000;175:679-685.
8. Ji H, McTavish JD, Mortele KJ et al. Hepatic imaging with multidetector CT. Radiographies 2001;21[spec no]:S71-80.
9. Hu H, He HD, Foley WD et al. Four multidetector-row helical CT: image quality and volume coverage speed. Radiology 2000; 215:55-62.
10. Mitsuzaki K, Yamashita Y, Ogata I et al. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing. AJR Am J Roentgenol 1996;167:753-757.
11. Murakami T, Kim T, Takahashi S et al. Hepatocellular carcinoma: multidetector row helical CT. Abdom Imaging 2002;27:139-146.
12. Paulson EK, McDermott VG, Keogan MT et al. Carcinoid metastases to the liver: role of triple-phase helical CT. Radiology 1998; 206:143-150.
13. Jones EC, Chezmar JL, Nelson RC et al. The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. AJR Am J Roentgenol 1992;158:535-539.
14. Schwartz LH, Gandras EJ, Colangelo SM et al. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 1999;210:71-74.
15. Kuszyk BS, Bluemke DA, Urban BA et al. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings. AJR Am J Roentgenol 1996;166:91-95.
16. Valls C, Andia E, Sanchez A et al. Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. Radiology 2001;218:55-60.
17. Kamel IR, Choti MA, Horton KM et al. Surgically staged focal liver lesions: accuracy and reproducibility of dual-phase helical CT for detection and characterization. Radiology 2003;227:752-757.
18. Soyer P. CT during arterial portography. Eur Radiol 1996;6:349-357.
19. Valls C, Lopez E, Guma A et al. Helical CT versus CT arterial portography in the detection of hepatic metastasis of colorectal carcinoma. AJR Am J Roentgenol 1998;170:1341-1347.
20. Kemmerer SR, Mortele KJ, Ros PR. CT scan of the liver. Radiol Clin North Am 1998;36:247-261.
21. Bonaldi VM, Bret PM, Reinhold C et al. Helical CT of the liver: value of an early hepatic arterial phase. Radiology 1995;197:357-363.
22. Hollett MD, Jeffrey RB Jr, Nino-Murcia M et al. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms. AJR Am J Roentgenol 1995;164:879-884.
23. Hanafusa K, Ohashi I, Himeno Y et al. Hepatic hemangioma: findings with two-phase CT. Radiology 1995;196:465-469.
24. Semelka RC, Brown ED, Ascher SM et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 1994;192:401-406.
25. Horton KM, Abrams RA, Fishman EK. Spiral CT of colon cancer: imaging features and role in management. Radiographics 2000; 20:419-430.
26. Soyer P, Bluemke DA, Vissuzaine C et al. CT of hepatic tumors: prevalence and specificity of retraction of the adjacent liver capsule. AJR Am J Roentgenol 1994;162:1119-1122.
27. Young ST, Paulson EK, Washington K et al. CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. AJR Am J Roentgenol 1994; 163:1385-1388.
28. Kamel IR, Georgiades C, Fishman EK. Incremental value of advanced image processing of multislice CT data in the evaluation of hypervascular liver lesions. J Comput Assist Tomogr 2003;27:652-656.
29. Lawler LP, Fishman EK. Multi-detector row CT of thoracic disease with emphasis on 3D volume rendering and CT angiography. Radiographics 2001;21:1257-1273.
30. Kamel IR, Kruskal JB, Pomfret EA et al. Impact of multidetector CT on donor selection and surgical planning before living adult right lobe liver transplantation. AJR Am J Roentgenol 2001;176:193-200.
31. Sahani D, Saini S, Pena C et al. Using multidetector CT for preoperative vascular evaluation of liver neoplasms: technique and results. AJR Am J Roentgenol 2002;179:53-59.
32. Dromain C, de Baere T, Elias D et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 2002;223:255-262.
33. Lencioni R, Cioni D, Bartolozzi C. Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging 2001;26:345-360.
34. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216.
35. Moertel CG, Hanley JA. The effect of measuring error on the results of therapeutic trials in advanced cancer. Cancer 1976;38:388-394.
36. Warr D, McKinney S, Tannock I. Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response. J Clin Oncol 1984;2:1040-1046.
37. Miller AB, Hoogstraten B, Staquet M et al. Reporting results of cancer treatment. Cancer 1981;47:207-214.
38. WHO. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: World Health Organization, 1979.
39. Tsuchida Y, Therasse P. Response evaluation criteria in solid tumors (RECIST): new guidelines. Med Pediatr Oncol 2001;37:l-3.
40. Padhani AR, Ollivier L. The RECIST (Response Evaluation Criteria in Solid Tumors) criteria: implications for diagnostic radiologists. Br J Radiol 2001;74:983-986.
41. Zeman RK, Fox SH, Silverman PM et al. Helical (spiral) CT of the abdomen. AJR Am J Roentgenol 1993;160:719-725.
42. Touliopoulos P, Costello P. Helical (spiral) CT of the thorax. Radiol Clin North Am 1995;33:843-861.
43. Prasad SR, Jhaveri KS, Saini S et al. CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology 2002;225:416-419.
44. Lencioni R, Cioni D, Bartolozzi C. Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound. Eur Radiol 2002;12:151-165.
45. Goldberg SN, Gazelle GS, Compton CC et al. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 2000;88:2452-2463.
46. Kuszyk BS, Boitnott JK, Choti MA et al. Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model. Radiology 2000;217:477-486.
47. Solbiati L, Ierace T, Goldberg SN et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997;202:195-203.
48. Curley SA, Izzo F, Delrio P et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1-8.
49. Goldberg SN, Gazelle GS, Solbiati L et al. Ablation of liver tumors using percutaneous RF therapy. AJR Am J Roentgenol 1998;170:1023-1028.
50. Solbiati L, Goldberg SN, Ierace T et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997;205:367-373.
51. Soulen MC. Chemoembolization of hepatic malignancies. Oncology (Huntingt) 1994;8:77-84; discussion 84, 89-90 passim.
52. Solomon B, Soulen MC, Baum RA et al. Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population. J Vasc Interv Radiol 1999;10:793-798.
53. Takayasu K, Arii S, Matsuo N et al. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol 2000;175:699-704.
54. Lim HK, Han JK. Hepatocellular carcinoma: evaluation of therapeutic response to interventional procedures. Abdom Imaging 2002;27:168-179.
55. Di Carlo V, Ferrari G, Castoldt R et al. Pre-operative chemoembolization of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 1998;45:1950-1954.
56. Paye F, Jagot P, Vilgrain V et al. Preoperative Chemoembolization of hepatocellular carcinoma: a comparative study. Arch Surg 1998; 133:767-772.
57. Huebner RH, Park KC, Shepherd JE et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000;41:1177-1189.
58. Wahl RL. Positron emission tomography in cancer patient management. Cancer J Sci Am 1999;5:205-207.
59. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61-77; quiz 150-151.
60. Delbeke D, Martin WH. Positron emission tomography imaging in oncology. Radiol Clin North Am 2001;39:883-917.
61. Whiteford MH, Whiteford HM, Yee LF et al. Usefulness of FDGPET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000; 43:759-767; discussion 767-770.